Pediatric ID News

The EG.5 omicron subvariant has emerged as the predominant SARS-CoV-2 virus during a summer wave of COVID-19 in the Unted States, accounting for 17.3% of cases, according to CDC tracking.

More than two out of every five infection-related deaths in the Americas in 2019 were associated with bacterial antimicrobial resistance, according to a new study.

A study of SARS-CoV-2 transmission in 10 Massachusetts school districts found that the secondary attack rate of SARS-CoV-2 among school contacts was low — between 2% and 3% — and that masking reduced the odds of transmission by almost 90%.

The CDC has recommended that infants be immunized with a monoclonal antibody against respiratory syncytial virus.

Researchers confirmed the dosing of an ART combination designed to treat children with HIV and found that it was safe, well tolerated and efficacious through 24 weeks, according to results published in The Lancet HIV.

This coming fall and winter, older adults in the United States will face a decision: Should they roll up their sleeves to receive the world’s first approved vaccines against respiratory syncytial virus?

One in six toddlers in the United States did not complete the vaccination series for seven recommended childhood vaccines in 2019, the year before the COVID-19 pandemic, according to a study published in Pediatrics.

Infectious diseases physician Jeanne M. Marrazzo, MD, MPH, will be the next director of the National Institute of Allergy and Infectious Diseases, the NIH announced Wednesday.

The prevalence of maternal hepatitis C virus infection has significantly increased in the U.S. since the start of the opioid epidemic in 1998, according to results from a cross-sectional study published in JAMA Network Open.

August is National Immunization Awareness Month. To mark the occasion, we compiled a list of vaccine stories you may have missed in 2023.